BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37527025)

  • 1. Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma.
    Leng D; Yang Z; Sun H; Song C; Huang C; Ip KU; Chen G; Deng CX; Zhang XD; Zhao Q
    Clin Cancer Res; 2023 Oct; 29(19):3986-4001. PubMed ID: 37527025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
    Wang T; Zhang XD; Hua KQ
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
    Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
    J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas.
    Zou D; Wang Y; Wang M; Zhao B; Hu F; Li Y; Zhang B
    Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33587010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.
    Shi D; Mu S; Pu F; Zhong B; Hu B; Liu J; He T; Zhang Z; Shao Z
    Front Cell Dev Biol; 2021; 9():652300. PubMed ID: 34277600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analyses of Stromal-Immune Score-Related Competing Endogenous RNA Networks In Colon Adenocarcinoma.
    Tong Y; Peng M; Li J; Niu Y
    Dis Markers; 2022; 2022():4235305. PubMed ID: 35607443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
    Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
    Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network.
    Zhou G; Jiang N; Zhang W; Guo S; Xin G
    Interdiscip Sci; 2021 Dec; 13(4):615-623. PubMed ID: 34472046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a New Immune-Related Competing Endogenous RNA Network with Prognostic Value in Lung Adenocarcinoma.
    Liu L; Li J; Fan C; Wen M; Li C; Sun W; Wang W
    Mol Biotechnol; 2024 Feb; 66(2):300-310. PubMed ID: 37118319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.
    Gao X; Zhang W; Jia Y; Xu H; Zhu Y; Pei X
    Sci Rep; 2022 Sep; 12(1):16247. PubMed ID: 36171401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
    Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
    Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
    Front Immunol; 2022; 13():914108. PubMed ID: 36032150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Role of miRNAs and lncRNAs in Gout.
    Shu J; Chen M; Ya C; Yang R; Li F
    Comput Math Methods Med; 2022; 2022():6513565. PubMed ID: 35813414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.